Loading...
Loading...
Browse all stories on DeepNewz
VisitWill the FDA revise Covid-19 vaccine authorization by end of 2025 due to RFK Jr.'s influence?
Yes • 50%
No • 50%
Official statement or policy change from the FDA
RFK Jr. Petitioned FDA in May 2021 to Revoke Covid-19 Vaccine Authorization Despite Saving 140,000 Lives
Jan 17, 2025, 10:28 PM
Robert F. Kennedy Jr., nominated by President-elect Donald Trump to lead the Department of Health and Human Services, petitioned the FDA in May 2021 to revoke the authorization of all Covid-19 vaccines. This action was taken during a critical phase of the pandemic when the vaccines were in high demand and considered life-saving, with estimates suggesting they had already saved about 140,000 lives in the United States. Kennedy's petition, filed on behalf of the nonprofit Children’s Health Defense, argued that the risks of the vaccines outweighed their benefits and suggested that alternative treatments like ivermectin and hydroxychloroquine were viable options, despite these treatments having been deemed ineffective against the virus. The FDA denied the petition, stating there was no basis to pull the vaccines from the market. Kennedy's stance on vaccines has drawn criticism, with some public health experts expressing concern over his potential impact on public health policy if confirmed as HHS Secretary.
View original story
Complete revocation • 25%
Looser regulations • 25%
Stricter regulations • 25%
No change • 25%
More favorable • 25%
Other • 25%
Unchanged • 25%
Less favorable • 25%
Yes • 50%
No • 50%
No significant change • 25%
Polarized opinions • 25%
Increased confidence • 25%
Increased skepticism • 25%
Other • 25%
Increased distribution • 25%
Decreased distribution • 25%
No change • 25%
More favorable • 25%
Divided opinion • 25%
No change • 25%
Less favorable • 25%
Supportive • 25%
Mixed reactions • 25%
Critical • 25%
Neutral • 25%
Increased vaccine skepticism • 25%
Insufficient data • 25%
No significant change • 25%
Decreased vaccine skepticism • 25%
No • 50%
Yes • 50%
Supports Both • 25%
Supports Neither • 25%
Supports Ivermectin • 25%
Supports Hydroxychloroquine • 25%
No significant change • 25%
Increase by more than 5% • 25%
Fluctuate without clear trend • 25%
Decrease by more than 5% • 25%